CSI Market
Sign In | Register

Bridgebio Pharma Inc (BBIO) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access BBIO Annual Balance Sheets →
The balance sheet data below highlights changes in Bridgebio Pharma Inc's financial position over recent quarters.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent677.91
Available-for-sale Securities, Debt Securities, Current MA42.25
Cash & Short-term Investments719.00
Accounts receivable254.48
Inventories52.84
Other Current Assets0.00
Prepaid Expense And Other Assets Current65.65
Total Current Assets1,093.14
Equipment/Property/Plant Net5.23
Intangible Assets26.64
Long-term investments55.10
Other Assets, Noncurrent37.20
Operating Lease Right Of Use Asset17.23
Total Assets1,217.30
Liabilities
Accounts Payable, Current AC27.20
Employee-related Liabilities, Current AC49.98
Long-term Debt, Current Maturities LO0.00
Other Liabilities, Current813.47
Deferred Revenue, Current DE0.00
Total Current Liabilities890.65
Long-term debt2,652.87
Total Long-term Debt2,652.87
Deferred Revenue, Noncurrent DE0.00
Other liabilities, Noncurrent179.67
Operating Lease Liability Current4.44
Convertible Senior Notes-
Operating Lease Liability Noncurrent14.22
Total Liabilities3,723.19
Stockholders' Equity
Temporary Equity Carrying Amount Net Including Portion Attributable To Noncontrolling Interests-0.95
Common Stock Value0.21
Treasury Stock Value0.00
Additional Paid In Capital Common Stock2,155.32
Retained Earnings / Accumulated Deficit-4,137.45
Accumulated Other Comprehensive Income-0.01
Other Equity-0.01
Common Stockholder's Equity-2,514.20
Non-controlling interests & other-1.02
Total Stockholder's Equity-2,515.22
Liabilities & Stockholder's Equity1,217.30
4 historic quarters locked

Sign in to unlock the full Bridgebio Pharma Inc balance sheet history.

Sign In Create Free Account

About Bridgebio Pharma Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001743881-26-000027

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.